Dr. Paul S. Bradshaw, PhD
Chief Operating Officer (COO)
Dr. Paul Bradshaw obtained his PhD from the Institute of Cancer Research (ICR) at the Royal Cancer (Marsden) Hospital, University of London, UK where he studied the neurological and cancer syndrome Ataxia-Telangiectasia (A-T). He subsequently undertook post-doctoral studies in the Program of Genetics and Genome Biology at the Hospital for Sick Children, Toronto, Canada before moving to the Department of Genetics and Development in the Krembil Research Institute at the University Health Network (UHN). Dr. Bradshaw joined Inteligex in 2018 where he heads corporate development.